Animal & Veterinary
CVM Appoints Three New Managers
FDA Veterinarian Newsletter March/April 2003 Volume XVIII, No 2
CVM has filled the positions of Deputy Associate Director for Policy and Regulations, Director of the Division of Therapeutic Drugs for Food Animals, and Director of the Division of Surveillance.
Dr. Bill Flynn has been selected as the Deputy Associate Director for Policy and Regulations, and will oversee the Policy and Regulations Staff responsible for developing Federal Register documents and guidance documents.
Dr. Flynn joined CVM in 1993 as a reviewer in the Division of Therapeutic Drugs for Food Animals where he also served as acting leader of the Antimicrobial Drugs Team. He later served as a Special Assistant in the Division of Human Food Safety and as Acting Deputy Director of ONADE.
Moving to the Office of the Director in 2001, Dr. Flynn concentrated on identifying and assessing emerging complex issues, most notably those dealing with the Center’s efforts to define scientifically based criteria for the regulation of antimicrobial drug products.
Most recently, Dr. Flynn successfully led the CVM Antimicrobial Resistance Guidance Group in its efforts to implement the Framework Document, culminating in the publication of draft Guidance for Industry #152, “Evaluating the Safety of Antimicrobial New Animal Drugs with Regard to Their Microbiological Effects on Bacteria of Human Health Concern.”
Dr. Flynn received his D.V.M. and M.S. in Veterinary Preventive Medicine from the Ohio State University.
Dr. Joan Gotthardt has been selected as the Director of the Division of Therapeutic Drugs for Food Animals in the Office of New Animal Drug Evaluation (ONADE), succeeding Dr. Steven Vaughn, now Director of ONADE. In this new capacity, Dr. Gotthardt will direct all activities related to the review of animal safety and effectiveness of therapeutic drugs and feed additives for food animals.
Dr. Gotthardt joined CVM in 1995. She received her D.V.M. from the Virginia Maryland Regional College of Veterinary Medicine. Previously, she worked in ONADE as a reviewer in the Antimicrobial Drugs Team, and as Leader of the Aquaculture Drugs Team. Before coming to CVM she worked as a supervisor in the Defense Mapping Agency. Dr. Gotthardt is assuming this critical leadership role at a time when ONADE is faced with many challenges including moving to a performance-based environment.
Dr. Lynn Post has been selected as Director of CVM’s Division of Surveillance in the Office of Surveillance and Compliance, succeeding Dr. Bill Keller, who retired last summer. In his new role, Dr. Post will direct all activities related to the evaluation of the safety and effectiveness of marketed animal drugs, special dietary feeds, veterinary medical devices, and other veterinary medical products. The Division of Surveillance also reviews product labeling and monitors and evaluates promotion of marketed veterinary drugs, and reports of adverse drug experiences.
Dr. Post received his D.V.M. from Texas A&M University. His graduate education includes an M.S. in veterinary toxicology and a Ph.D. in toxicology from Louisiana State University. He is a Diplomate of the American Board of Veterinary Toxicology and also the Chair of the Exam Committee.
In 1994, Dr. Post came to CVM as a veterinary medical officer in the Division of Production Drugs, ONADE. He transferred to OS&C, Division of Surveillance, as a reviewer in 1998. He was appointed as the Adverse Drug Event Coordinator in 2000, and served as the VICH Chair of the Pharmacovigilance Expert Working Group that met in Tokyo, Japan during October 2002. Dr. Post has been the Acting Director for the Division of Surveillance since July 2002, and has received numerous awards and commendations as a Commissioned Corps Officer of the Public Health Service.